South Wales, Nov. 20 -- UK Intellectual Property Office has received a patent application (GB2611154.2) with the title ‘COMPACT MELANOPSIN-TARGETED PHOTOTHERAPY SYSTEM WITH GPS-CALIBRATED PROTOCOL DELIVERY, HOST-DEVICE INTEGRATION VIA BIDIRECTIONAL DATA INTERFACE, AND PHONE-NATIVE AMBIENT DOSE TRACKING.’

Here are the other details related to the patent application:

Status: Filed

Filing Date: 2026-05-13

Owner(s): SENSIO BIOLABS LTD

Disclaimer: Curated by HT Syndication.